Page last updated: 2024-10-21

7-hydroxy-2-n,n-dipropylaminotetralin and Chronic Disease

7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with Chronic Disease in 1 studies

7-hydroxy-2-N,N-dipropylaminotetralin: RN given refers to cpd without isomeric designation

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kozyrev, N1
Staudt, MD1
Brown, A1
Coolen, LM1

Other Studies

1 other study available for 7-hydroxy-2-n,n-dipropylaminotetralin and Chronic Disease

ArticleYear
Chronic Contusion Spinal Cord Injury Impairs Ejaculatory Reflexes in Male Rats: Partial Recovery by Systemic Infusions of Dopamine D3 Receptor Agonist 7OHDPAT.
    Journal of neurotrauma, 2016, 05-15, Volume: 33, Issue:10

    Topics: Animals; Chronic Disease; Disease Models, Animal; Dopamine Agonists; Ejaculation; Electric Stimulati

2016